By Eva Mathews Nov 30 (Reuters) - Struggling British bootmaker Dr Martens is planning to sell pre-owned and refurbished boots in the United States next year to attract shoppers looking to save cash, Chief Executive Kenny Wilson told Reuters. Dr Martens is trying to create new sales opportunities after issuing its fourth profit warning since last November on Thursday, partly blaming lacklustre U.S. demand. Its stock has lost more than three-quarters of its value since it listed on the London Stock Exchange in 2021. The maker of the popular 1460 boots with yellow stitching plans to launch a service called 'Rewear' in the first half of 2024 after a successful trial in Britain, its home market, Wilson said in an interview after the company's first-half results. Wilson did not specify details on how much the pricing would differ compared with the 159 pounds ($201) and upwards for a new pair of its classic lace-up boots. Customers can exchange their old pairs for a gift card. Dr Martens is also looking to launch boots made of recycled leather in the first half of 2024 as it looks to satisfy younger shoppers more conscious of sustainability issues, Wilson said. Persistent inflation and high mortgage rates have dented shoppers' ability to spend, pushing up demand for second-hand goods. Manufacturers have responded by offering refurbished or second hand goods, recognising their new products are out of reach for some shoppers. Clothing and footwear brands including Inditex's Zara and H&M are also seeking a toehold in the resale market to appeal to young shoppers opting for second-hand over new. Dr Martens, whose boots are worn by celebrities including Kourtney Kardashian, recently launched a shoe repair service in Britain. "In the first month, we've done somewhere between 500 and 1,000 repairs and the feedback has been fantastic," Wilson said. ($1 = 0.7908 pounds) (Reporting by Eva Mathews in Bengaluru; Editing by Matt Scuffham and Emelia Sithole-Matarise)
Struggling bootmaker Dr Martens jumps in on second-hand craze
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...